Atara Bio hikes IPO target from $50 million to $92 million
July 10, 2014 at 20:41 PM EDT
Atara Biotherapeutics Inc. supersized its planned IPO to up to $92 million, offering 5.75 million shares at a range of $14 to $16 each...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|